Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (1578)	6/3/2003 7:08:19 PM
From: microcapfun	Read Replies (1) of 3044

Jeez. The entire issue is on proteosome inhibition. --- Cancer Treatment Reviews Copyright © 2003 Elsevier Science Ltd. All rights reserved Volume 29, Supplement 1, Pages 1-57 (May 2003) Display Checked Docs \| E-mail Articles \| Export Citations View: Citations Partial Abstracts + Citations Full Abstracts + Citations 1. Proteasome inhibition: a new pathway in cancer therapy, Pages 1-2 William S. Dalton SummaryPlus \| Full Text + Links \| PDF (53 K) -------------------------------------------------------------------------------- 2. The proteasome: structure, function, and role in the cell, Pages 3-9 Julian Adams SummaryPlus \| Full Text + Links \| PDF (321 K) -------------------------------------------------------------------------------- 3. The tumor microenvironment: focus on myeloma, Pages 11-19 William S. Dalton SummaryPlus \| Full Text + Links \| PDF (232 K) -------------------------------------------------------------------------------- 4. Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib, Pages 21-31 James C. Cusack SummaryPlus \| Full Text + Links \| PDF (303 K) -------------------------------------------------------------------------------- 5. Clinical update: proteasome inhibitors in hematologic malignancies, Pages 33-39 Paul Richardson SummaryPlus \| Full Text + Links \| PDF (184 K) -------------------------------------------------------------------------------- 6. Clinical update: proteasome inhibitors in solid tumors, Pages 41-48 Heinz-Josef Lenz SummaryPlus \| Full Text + Links \| PDF (165 K) -------------------------------------------------------------------------------- 7. Therapeutic anti-cancer targets upstream of the proteasome, Pages 49-57 Grzegorz Nalepa and J. Wade Harper SummaryPlus \| Full Text + Links \| PDF (336 K) --------------------------------------------------------------------------------

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next